Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: A phase IIa study of the AGO Study Group
Baumann, K, Pfisterer, J, Wimberger, P, Burchardi, N, Kurzeder, C, du Bois, A, Loibl, S, Sehouli, J, Huober, J, Schmalfeldt, B, Vergote, I, Lück, H.J, Wagner, U
Published in Gynecologic oncology (01.10.2011)
Published in Gynecologic oncology (01.10.2011)
Get full text
Journal Article
5035 The patient's anastrozole compliance to therapy programme (PACT): evaluating the influence of a standardized information service on compliance in postmenopausal women with early breast cancer
Jackisch, C.H, Harbeck, N, Blettner, M, Hadji, P, Lück, H.J, Schmitt, D.C, Haidinger, R, Köhler, U, Zaun, S, Kreienberg, R
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
Simultaneous hemodynamic and serological cardiotoxicity monitoring during immunotherapy with trastuzumab
Knobloch, K, Tepe, J, Lichtinghagen, R, Luck, H.J, Vogt, P.M
Published in International journal of cardiology (28.03.2008)
Published in International journal of cardiology (28.03.2008)
Get full text
Journal Article
Validation of the MammaTyper® pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC)
Fasching, P.A., Laible, M., Weber, K.E., Wirtz, R.M., Denkert, C., Schlombs, K., Schmatloch, S., Camara, O., Lück, H.J., Huober, J., Karn, T., van Mackelenbergh, M.T., Marme, F., Müller, V., Schem, C., Stickeler, E., Sahin, U., Loibl, S., Untch, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Evaluation of the MammaTyper® as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes
Fasching, P.A., Laible, M., Weber, K.E., Wirtz, R.M., Denkert, C., Schlombs, K., Schmatloch, S., Camara, O., Lück, H.J., Huober, J., Karn, T., van Mackelenbergh, M.T., Marme, F., Müller, V., Schem, C., Stickeler, E., Sahin, U., Loibl, S., Untch, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Combined NT–pro-BNP and CW-Doppler ultrasound cardiac output monitoring (USCOM) in epirubicin and liposomal doxorubicin therapy
Knobloch, K, Tepe, J, Rossner, D, Lichtinghagen, R, Luck, H.J, Busch, K.H, Vogt, P.M
Published in International journal of cardiology (29.08.2008)
Published in International journal of cardiology (29.08.2008)
Get full text
Journal Article
Multicenter phase II study of oral capecitabine (Xeloda“) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy
Reichardt, P., von Minckwitz, G., Thuss-Patience, P. C., Jonat, W., Kölbl, H., Jänicke, F., Kieback, D. G., Kuhn, W., Schindler, A. E, Mohrmann, S., Kaufmann, M., Lück, H. J.
Published in Annals of oncology (01.08.2003)
Published in Annals of oncology (01.08.2003)
Get full text
Journal Article
Advanced epithelial ovarian cancer : 1998 consensus statements
BEREK, J. S, BERTELSEN, K, HARPER, P. G, HORVATH, G, KAYE, S. B, LÜCK, H. J, LUND, B, MCGUIRE, W. P, NEIJT, J. P, OZOLS, R. F, PARMAR, M. K. B, PICCART-GEBHART, M. J, DU BOIS, A, VAN RIJSWIJK, R, ROSENBERG, P, RUSTIN, G. J. S, SESSA, C, THIGPEN, J. T, TROPE, C, TUXEN, M. K, VERGOTE, I, VERMORKEN, J. B, WILLEMSE, P. H. B, BRADY, M. F, CARMICHAEL, J, EISENHAUER, E. A, GORE, M, GRENMAN, S, HAMILTON, T. C, HANSEN, S. W
Published in Annals of oncology (1999)
Published in Annals of oncology (1999)
Get full text
Conference Proceeding
Journal Article
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial
Untch, M, Eidtmann, H, du Bois, A, Meerpohl, H.G, Thomssen, Ch, Ebert, A, Harbeck, N, Jackisch, C, Heilman, V, Emons, G, Wallwiener, D, Wiese, W, Blohmer, J.-U, Höffken, K, Kuhn, W, Reichardt, P, Muscholl, M, Pauschinger, M, Langer, B, Lück, H.J
Published in European journal of cancer (1990) (01.05.2004)
Published in European journal of cancer (1990) (01.05.2004)
Get full text
Journal Article
Patient's Anastrozole Compliance to Therapy Programme (PACT) influence of the addition of a standardized information and reminder service on compliance in comparison to standard clinical care alone in women with early breast cancer
Hadji, P, Blettner, M, Haidinger, R, Harbeck, N, Jackisch, C, Luck, H.J, Martin, R.R, Rexrodt von Fircks, A, Schmitt, D.C, Kreienberg, R
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article
Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer—a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group
du Bois, A., Lück, H. J., Pfisterer, J., Schroeder, W., Blohmer, J. U., Kimmig, R., Moebus, V., Quaas, J.
Published in Annals of oncology (01.08.2001)
Published in Annals of oncology (01.08.2001)
Get full text
Journal Article
Chemotherapy versus hormonal treatment in platinum- and paclitaxel-refractory ovarian cancer: a randomised trial of the German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Ovarian Cancer
DU BOIS, A, MEIER, W, RICHTER, B, WAGNER, U, LÜCK, H. J, EMONS, G, MOEBUS, V, SCHROEDER, W, COSTA, S, BAUKNECHT, T, OLBRICHT, S, JACKISCH, C
Published in Annals of oncology (01.02.2002)
Published in Annals of oncology (01.02.2002)
Get full text
Journal Article
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer
Untch, M, Eidtmann, H, du Bois, A, Meerpohl, H.G, Thomssen, Ch, Ebert, A, Harbeck, N, Jackisch, C, Heilman, V, Emons, G, Wallwiener, D, Wiese, W, Blohmer, J.-U, Höffken, K, Kuhn, W, Reichardt, P, Muscholl, M, Pauschinger, M, Langer, B, Lück, H.J
Published in European journal of cancer (1990) (01.05.2004)
Published in European journal of cancer (1990) (01.05.2004)
Get full text
Journal Article
Meta-analysis of taxanes alone or in combination with anthracyclines versus non taxane-based regimens as first-line therapy of patients with metastatic breast cancer (MBC): a lesson from the past and a message for the future
Piccart, M., Burzykowski, T., Buyse, M., Nabholtz, J.M., Carmichael, J., Lück, H.J., Sledge, G., Paridaens, R., Biganzoli, L., Therasse, P.
Published in European journal of cancer supplements (01.03.2006)
Published in European journal of cancer supplements (01.03.2006)
Get full text
Journal Article
Capecitabine: The new standard in metastatic breast cancer failing anthracycline and taxane-containing chemotherapy? Mature results of a large multicenter phase II trial
Reichardt, P., von Minckwitz, G., Lück, H.J., Thuss-Patience, P.C., Jonat, W., Kölbl, H., Kiebak, D., Kuhn, W., Floemer, F., Frings, S.
Published in European journal of cancer (1990) (01.04.2001)
Published in European journal of cancer (1990) (01.04.2001)
Get full text
Journal Article
Treatment of patients with advanced ovarian cancer (FIGO IIb-IV) with cisplatin/paclitaxel or carboplatin/paclitaxel — An interim analysis of the ago study protocol ovar-3
Schröder, W., du Bois, A., Kuhn, W., Lück, H.J., Möbus, V., Meier, W., Nitz, U., Olbricht, S., Pfisterer, J.
Published in European journal of cancer (1990) (01.09.1999)
Published in European journal of cancer (1990) (01.09.1999)
Get full text
Journal Article
Gemcitabine (G) + carboplatin (C) as 2nd line therapy in gynaecologic cancer patients: a phase I/II study of the arbeitsgemeinschaft Gynäkologische Onkologie (AGO) study group
Quaas, J., Lück, H.J., Schröder, W., Blohmer, J., Kimmig, R., Möbus, V., Pfisterer, J.
Published in International journal of gynecology and obstetrics (2000)
Published in International journal of gynecology and obstetrics (2000)
Get full text
Journal Article
Gemcitabine (G) + carboplatin (C) as 2 nd line therapy in gynaecologic cancer patients: a phase I/II study of the arbeitsgemeinschaft Gynäkologische Onkologie (AGO) study group
Quaas, J., Lück, H.J., Schröder, W., Blohmer, J., Kimmig, R., Möbus, V., Pfisterer, J.
Published in International journal of gynecology and obstetrics (2000)
Published in International journal of gynecology and obstetrics (2000)
Get full text
Journal Article
41 HER2-expression in advanced ovarian cancer: A prognostic and predictive marker? An study of the AGO ovarian study group
Lück, H.J., Kommoss, F., Riener, E., Arnold, N., Adams, H.P., Hilpert, F., Du Bois, A., Pfisterer, J.
Published in European journal of cancer supplements (01.09.2003)
Published in European journal of cancer supplements (01.09.2003)
Get full text
Journal Article